Thursday, September 10, 2020
Scientists engineer DNA-based nanotechnology to stimulate potent antitumor immune responses
Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies.
No comments:
Post a Comment